Siglec6, also known as CD327, this gene encodes a member of the SIGLEC (sialic acid binding immunoglobulin-like
lectin) family of proteins. The encoded transmembrane receptor binds sialyl-TN glycans and leptin. Placental
expression of the encoded protein is upregulated in preeclampsia. Immunomodulatory Siglecs are controlled by
their glycoprotein and glycolipid ligands, Siglec-6 can recognize glycolipids independent of its canonical binding
pocket, suggesting that Siglec-6 possesses a secondary binding pocket tailored for recognizing glycolipids in a bilayer.
The selective, stable expression and potent inhibitory capacity of Siglec-6 on human mast cells are favorable for its use as a therapeutic target in mast cell-driven diseases.